Invivyd, Inc.(IVVD)
Biotechnology
Antibody Engineering (mAbs, bispecifics, ADCs)
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-02-18 | Allen Robert D. III Chief Scientific Officer | Sale | -37,581 | -24.71%114,487 | $1.56 | $58,600 | View SEC filing | |
| 2026-02-18 | Green Julie Chief Human Resources Officer | Sale | -40,627 | -27.39%107,717 | $1.56 | $63,350 | View SEC filing | |
| 2026-02-18 | Duke William E. Chief Financial Officer | Sale | -40,627 | -27.39%107,717 | $1.56 | $63,350 | View SEC filing | |
| 2026-02-18 | Lee Timothy Edward Chief Commercial Officer | Sale | -40,627 | -25.66%117,717 | $1.56 | $63,350 | View SEC filing | |
| 2026-02-18 | Andersen Jill Chief Legal Officer, Secretary | Sale | -67,710 | -27.14%181,736 | $1.56 | $105,581 | View SEC filing | |
| 2025-11-20 | MCLAUGHLIN KEVIN F Director | Purchase | +50,000 | +100.00%50,000 | $2.50 | $125,000 | View SEC filing | |
| 2025-08-19 | Lee Timothy Edward Chief Commercial Officer | Sale | -49,656 | -45.56%59,344 | $0.60 | $29,808 | View SEC filing | |
| 2025-08-19 | Duke William E. Chief Financial Officer | Sale | -49,656 | -50.16%49,344 | $0.60 | $29,808 | View SEC filing | |
| 2025-08-19 | Green Julie Chief Human Resources Officer | Sale | -49,656 | -50.16%49,344 | $0.60 | $29,808 | View SEC filing | |
| 2025-08-19 | Andersen Jill Chief Legal Officer, Secretary | Sale | -82,754 | -49.49%84,446 | $0.60 | $49,677 | View SEC filing | |
| 2025-08-19 | Allen Robert D. III Chief Scientific Officer | Sale | -45,932 | -46.40%53,068 | $0.60 | $27,573 | View SEC filing | |
| 2024-12-31 | MCGUIRE TERRANCE Director | Sale | -273,763 | -8.20%3,066,757 | $0.48 | $131,529 | View SEC filing | |
| 2024-12-26 | MCGUIRE TERRANCE Director | Sale | -347,559 | -9.42%3,340,520 | $0.47 | $164,868 | View SEC filing | |
| 2024-12-19 | MCGUIRE TERRANCE Director | Sale | -324,241 | -8.08%3,688,079 | $0.46 | $147,795 | View SEC filing | |
| 2024-12-16 | MCGUIRE TERRANCE Director | Sale | -190,359 | -4.53%4,012,320 | $0.54 | $103,385 | View SEC filing | |
| 2024-12-11 | MCGUIRE TERRANCE Director | Sale | -485,400 | -10.35%4,202,679 | $0.60 | $289,377 | View SEC filing | |
| 2024-05-31 | MCGUIRE TERRANCE Director | Sale | -112,381 | -2.34%4,688,079 | $1.66 | $186,575 | View SEC filing | |
| 2024-01-22 | Adimab, LLC 10% Owner | Sale | -5,000,000 | -18.74%21,687,906 | $3.95 | $19,750,000 | View SEC filing | |
| 2022-09-01 | Hering David Chief Executive Officer | Purchase | +8,000 | +100.00%8,000 | $4.52 | $36,160 | View SEC filing | |
| 2022-08-19 | M28 Capital Management LP Other | Purchase | +2,850,000 | +44.54%9,248,250 | $4.28 | $12,194,680 | View SEC filing | |
| 2021-08-12 | Royan Ajay Director, 10% Owner | Purchase | +1,997,000 | +21.60%11,241,580 | $17.00 | $33,949,000 | View SEC filing | |
| 2021-08-12 | THIEL PETER 10% Owner | Purchase | +1,997,000 | +21.60%11,241,580 | $17.00 | $33,949,000 | View SEC filing | |
| 2021-08-12 | MCGUIRE TERRANCE Director | Purchase | +500,000 | -82.55%497,660 | $17.00 | $8,500,000 | View SEC filing | |
| 2021-08-12 | Redmile Group, LLC 10% Owner | Purchase | +1,470,000 | +76.52%3,390,960 | $17.00 | $24,990,000 | View SEC filing |
1-24 of 24